Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events

NACompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

April 12, 2017

Primary Completion Date

April 23, 2019

Study Completion Date

April 24, 2019

Conditions
Pulmonary ThromboembolismsPulmonary Embolism
Interventions
DEVICE

4DCT and SPECT/CT

Each patient will receive two 4DCT followed by SPECT/CT.

DEVICE

4DCT with BiPAP and SPECT/CT

Each patient will receive two 4DCT, with the second scan obtained with positive pressure breathing via BiPAP, followed by SPECT/CT

DEVICE

4DCT with CTA in suspected PE

Each patient will receive 4DCT before or after CTA for suspected PE

Trial Locations (1)

48073

William Beaumont Hospital, Royal Oak

All Listed Sponsors
lead

Thomas Guerrero

OTHER

NCT03183063 - Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events | Biotech Hunter | Biotech Hunter